Therapeutic options for patients with myeloma have radically changed over thepast ten years. Beginning with the advances in therapy resulting from the useof high dose therapy and autologous bone marrow or stem cell transplant, we have more than doubled the median survival for patients as a whole, and have now a wealth of different biology based treatment approaches for our patients inall disease stages. The purpose of this book is to update the various treatment options for patients with myeloma, as well as to focus on the emerging and speculative aspects of myeloma therapy. This will require review of basic mechanisms of disease as well as further discussions on how these mechanisms can best be targeted. While there will be text covering most areas of myeloma therapy, the prime focus of the book will be the novel agents currently in testing as well as potential future novel targets and agents. Impressive collection ofmyeloma development, a rapidly growing area of clinical, laboratory and research interest Presents significant material on the biology and potential agentsused to address specific signaling pathways critical to myeloma biology and therapy Updated various treatment options for patients with myeloma Focuses on the emerging and speculative aspects of myeloma therapy INDICE: From the contents Section 1: Biologic Considerations and Myeloma. Section 2: Historical and Cytotoxic Agent based Therapies for Myeloma. Section3: Immune Based Therapies. Section 4: Existing novel agents. Section 5: Current and Future Targets. Section 6: Supportive Care. Section 7: Other Plasma Cell Disorders.
- ISBN: 978-1-934115-82-4
- Editorial: Humana
- Encuadernacion: Cartoné
- Páginas: 565
- Fecha Publicación: 01/09/2008
- Nº Volúmenes: 1
- Idioma: Inglés